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A wealth of evidence supports the developmental period as being an important determinant for 
future health status, as well as life expectancy. Intrauterine growth restriction (IUGR), or failure of 
the fetus to reach its full growth and developmental potential, can occur for many reasons. 
Abnormal or insufficiently small placental development can induce IUGR, with the latter often 
occurring secondary to maternal hypertensive disorders such as pre-eclampsia (PE). During 
pregnancy, the placenta has many roles including providing a functional interface between separate 
maternal and fetal circulatory systems to allow nutrient, waste and gas exchange. Consequently, 
poor placentation leads to a reduction in maternal-fetal transfer particularly of oxygen (O2), 
impeding fetal growth and development. 
Today IUGR remains a leading cause of perinatal mortality, morbidity and in the long-term, IUGR 
infants have an increased risk of developing later-life cardiometabolic complications including 
hypertension and Type 2 diabetes. Moreover, accumulating evidence suggests that IUGR and low 
birth weight lead to the early onset of markers of age-related decline or frailty, such as reduced grip 
strength and alterations in muscle fibre distribution associated with insulin resistance (Jensen et al., 
2007). As highlighted in this current issue of The Journal of Physiology, maternal-fetal hypoperfusion 
necessitates a hard choice; the sparing of critical fetal organs by limiting nutrient/O2 delivery and 
utilisation by non-essential fetal tissue beds.  
It is unsurprising that maintaining O2 and nutrient delivery to the fetal heart and brain is paramount 
to fetal survival and normal development. Brain sparing is evident in response to both acute hypoxic 
challenge (Yaffe et al., 1987) as well as chronic hypoxic conditioning (Allison et al., 2016). In this 
issue, Rozance and colleagues utilised a well-validated sheep model of temperature-induced 
placental insufficiency to examine how fetal hindlimb blood flow, hormonal levels and metabolic 
substrate use correlate with muscle protein accretion in IUGR foetuses (Rozance et al., 2017). In 
agreement with other published studies (Yates et al., 2014), the authors report IUGR is associated 
with a lower daily fetal muscle mass growth rate, leading to a reduction in adrenergic and insulin-
responsive Type I and IIa myofiber area. As Type IIa fibre area inversely correlates with fasting 
plasma glucose in adult low birth weight adult males (Jensen et al., 2007), the phenotypic alterations 
reported by Rozance and colleagues may represent early adaptive changes in offspring, potentially 
priming them towards later insulin resistance.  
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But what are the factor(s) limiting IUGR fetal muscle mass? Whilst the authors rule out enhanced 
protein catabolism as the cause of reduced muscle protein accretion, their most interesting findings 
attempt to address why muscle protein synthesis may be compromised in IUGR. As demonstrated in 
the current study, absolute blood flow, fetal arterial PaO2, O2 saturation, O2 content and glucose 
levels are lower in IUGR. However, when considering blood flow relative to fetal hindlimb mass, 
blood flow, glucose uptake and lactate output are not different between healthy and IUGR fetuses. 
In contrast, O2 delivery and O2 consumption are significantly lower in IUGR fetuses, as is hindlimb 
total amino acid uptake relative to muscle mass. The authors further demonstrate a clear 
relationship between O2 saturation, hindlimb glucose, amino acid uptake and hindlimb mass, 
however it is the reduction in the amino acid-O2 quotient in IUGR rather than an alteration in 
glucose+lactate-O2 quotient which reveals that amino acid uptake may be key to determining the 
rate of muscle protein synthesis.  
The significance of this relationship should not be underestimated. Under normal conditions, as 
gestation progresses fetal O2 demand increases to outpace uterine blood flow and placental 
exchange, leading to a modest reduction in fetal PaO2 and potentially glucose levels. In IUGR, failure 
of the maternal uterine vessels and placenta to sufficiently adapt exacerbates this deficit. If growth 
in IUGR fetuses were to occur at the normal rate, the lower fetal O2 saturation would cause oxidative 
metabolism to become compromised, initiating amino acid oxidation and protein catabolism to 
maintain its basal metabolic rate (Fig. 1).  
Furthermore, the study by Rozance and colleagues implicates a critical role for Insulin-like growth 
factor-1 (IGF-1) in positively regulating fetal skeletal muscle growth. IGF-1 receptor mutations have 
previously been linked to the development of IUGR and as discussed by the authors, deletion of IGF-
1 is associated with a reduction in murine muscle mass (Liu et al., 1993), with IGF-1 also reported to 
exert anabolic actions in other target tissues. It has yet to be determined whether in IUGR, IGF-1 
affects total amino acid uptake or if its actions may be more selective. Similarly, definitive evidence 
is needed to define whether previous associations observed between the rate of fetal liver perfusion 
via the ductus venosus and IGF-1 production translate to fetal skeletal muscle O2 content and 
consequently amino acid transport, protein synthesis and muscle accretion. To conclude, studies of 
adverse pregnancy continue to improve our understanding of the physiological cues guiding fetal 
development and growth. As in the present study of IUGR, it is clear that messing with tissue-specific 
metabolic substrate supply and demand during pregnancy has developmental and long lasting 
consequences for the fetus.  
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Figure legend: 
 
Fig. 1 IUGR is associated with lower skeletal muscle amino acid uptake and O2 consumption 
leading to reduced muscle mass 
Placental insufficiency reduces fetal O2 supply, decreasing IGF-1 levels resulting in reduced muscle 
amino acid uptake, which matches a reduced muscle O2 supply and O2 consumption. Consequently, 
protein synthesis is reduced, leading to a lower muscle mass and loss of Type I and Type IIa fibre 
number in various skeletal muscle beds. As noted in italics, these alterations may be linked with 
brain sparing due to reduced liver perfusion, as more blood bypasses the liver via the ductus 
  
 
This article is protected by copyright. All rights reserved. 
 
venosus, which may also lead to lower IGF-1 production. Alterations in fetal skeletal muscle 
phenotype may increase its propensity to become insulin resistant in later-life.   
 
